Altria Group, Inc. · MO · Next earnings

Altria Group, Inc. reports Thursday, Oct 29, 2026

MO reports before market open with consensus EPS at $1.50 and revenue at $5.32B. Last quarter: Altria Q1 2026: EPS Beats 5.6% as Marlboro Hits 59.5% Premium Share and on! PLUS Goes Nationwide

Reports Before market open39 days awayDate estimated Consumer Defensive

What the street expects

Consensus for the coming report
Consensus EPS $1.50 Calendar consensus
Consensus revenue $5.32B Calendar consensus
Report date Oct 29, 2026 Thursday, date estimated
Session Before market open 39 days away

Where MO left off: FY2026 Q1

Full report

Altria Q1 2026: EPS Beats 5.6% as Marlboro Hits 59.5% Premium Share and on! PLUS Goes Nationwide

EPS surprise +5.6% Reported $1.32 vs $1.25
Revenue surprise +3.9% Reported $4.76B vs $4.58B
Stock move +6.5% Event window
Subsequent drift -4.2% Up to 20 sessions

Full-year 2026 adjusted EPS guidance of $5.56-$5.72 was reaffirmed despite the stronger Q1 print. Management cited expectations of more balanced growth between H1 and H2, implying a deceleration in subsequent quarters. This maintained guidance, rather than a raise, was a focal analyst concern given the Q1 beat created a ~$0.07 EPS cushion above the $1.25 consensus.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Persistent macroeconomic pressure from inflation and rising gas prices affecting discretionary spending.
  • Regulatory uncertainty around FDA authorizations for new nicotine pouch flavors and e-vapor products.
  • Continued presence of illicit disposable e-vapor products disrupting market dynamics.
  • Cross-category movement between cigarettes and e-vapor potentially eroding smokeable volumes.

Questions analysts left open

  • Why guidance was not raised despite stronger-than-expected Q1 performance.
  • Sustainability of cigarette volume recovery and discount vs. premium dynamics.
  • Phasing and magnitude of the duty drawback benefit throughout the year.
  • Early consumer adoption and sales trajectory for on! PLUS.
  • Strategic approach to e-vapor market amid enforcement and FDA authorization delays.

Ask FN2 about MO next report

Transcript, numbers and history already loaded
What should I watch for in MO's next earnings report?How did MO guide last quarter, and is consensus above or below that?Give me the bull and bear case going into MO earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the MO recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent MO quarters

All MO earnings
+6.5%FY2026 Q1

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q1

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.